Preventive effects of medium-chain triglycerides supplementation on the oxidative capacity in skeletal muscle under cachectic condition

Biomed Res. 2020;41(4):179-186. doi: 10.2220/biomedres.41.179.

Abstract

Cachexia is a multifactorial condition characterized by muscle mass loss and induces metabolic dysfunction of the skeletal muscles. The preventive effects of medium-chain triglycerides (MCT) supplementation on the oxidative capacity in skeletal muscle under cachectic condition were investigated in the present study. ICR mice were randomly divided into four groups; control, lipopolysaccharide (LPS), LPS plus long-chain triglycerides (LCT) and LPS plus MCT supplementation. LCT and MCT oil were administered to the LPS + LCT and LPS + MCT groups orally (5.0 g/kg body weight/day) by a catheter for one week. Cachexia was induced in the LPS, LPS + LCT, and LPS + MCT groups via LPS injection (7.5 mg/kg body weight, i.p.) after the supplementation. LPS induced a reduction of ketone bodies concentration in blood plasma. LPS also induced a decrease in succinate dehydrogenase activity and PGC-1α expression level in tibialis anterior muscles. Meanwhile, MCT supplementation suppressed a decrease in ketone bodies concentration and succinate dehydrogenase activity. In addition, MCT supplementation increased the level of citrate synthase activity in the muscles. These results suggested the preventive effect of MCT supplementation on oxidative capacity in skeletal muscle and the involvements of ketone bodies regulation under cachectic condition.

MeSH terms

  • Animals
  • Body Weight / drug effects
  • Cachexia / genetics
  • Cachexia / metabolism
  • Cachexia / pathology
  • Cachexia / prevention & control*
  • Citrate (si)-Synthase / genetics
  • Citrate (si)-Synthase / metabolism
  • Dietary Supplements*
  • Gene Expression Regulation
  • Ketone Bodies / blood
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / antagonists & inhibitors*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Oxidative Phosphorylation / drug effects
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / genetics
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / metabolism
  • Succinate Dehydrogenase / genetics
  • Succinate Dehydrogenase / metabolism
  • Triglycerides / chemistry
  • Triglycerides / pharmacology*

Substances

  • Ketone Bodies
  • Lipopolysaccharides
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Ppargc1a protein, mouse
  • Triglycerides
  • Succinate Dehydrogenase
  • Citrate (si)-Synthase